Monoclonal antibodies directed at growth factor receptors

被引:24
作者
Baselga, J [1 ]
机构
[1] Hosp Gen Univ Vall Hebron, Barcelona, Spain
关键词
D O I
10.1023/A:1011144502974
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:187 / 190
页数:4
相关论文
共 8 条
[1]   Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin [J].
Baselga, J ;
Pfister, D ;
Cooper, MR ;
Cohen, R ;
Burtness, B ;
Bos, M ;
D'Andrea, G ;
Seidman, A ;
Norton, L ;
Gunnett, K ;
Falcey, J ;
Anderson, V ;
Waksal, H ;
Mendelsohn, J .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) :904-914
[2]  
EZEKIEL MP, 1999, P AM SOC CLIN ONCOL, V18, pA1501
[3]  
MENDELSOHN J, 1999, P AN M AM SOC CLIN, V18, pA1502
[4]   Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer [J].
Modjtahedi, H ;
Hickish, T ;
Nicolson, M ;
Moore, J ;
Styles, J ;
Eccles, S ;
Jackson, E ;
Salter, J ;
Sloane, J ;
Spencer, L ;
Priest, K ;
Smith, I ;
Dean, C ;
Gore, M .
BRITISH JOURNAL OF CANCER, 1996, 73 (02) :228-235
[5]  
NORTON L, 1999, P AN M AM SOC CLIN, V18, P483
[6]   TUMOR EPIDERMAL GROWTH-FACTOR RECEPTOR STUDIES IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER OR HEAD AND NECK-CANCER TREATED WITH MONOCLONAL-ANTIBODY RG-83852 [J].
PEREZSOLER, R ;
DONATO, NJ ;
SHIN, DM ;
ROSENBLUM, MG ;
ZHANG, HZ ;
TORNOS, C ;
BREWER, H ;
CHAN, JC ;
LEE, JS ;
HONG, WK ;
MURRAY, JL .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :730-739
[7]  
RUBIN M, 2000, P AM SOC CLIN ONCOL
[8]  
SLAMON D, 1998, P AM SOC CLIN ONCOL